ÂÜÀòÂÒÂ×

Dr Shore MD, FACS is the Chief Medical Officer of Urology/Surgical Oncology at GenesisCare, US and the Medical Director of Carolina Urologic Research Centre. He has conducted more than 400 clinical trials with a particular focus on genitourinary (GU) oncology indications and is an internationally recognised expert and researcher in systemic therapies for patients with advanced urologic cancers, such as prostate, kidney and bladder cancers.

Dr Shore has more than 250 peer reviewed publications and numerous book chapters. He completed his general surgery/urology residence at New York Hospital-Cornell Medical Center/Memorial Sloan Kettering Cancer Center. Dr Shore serves on the SITC Guidelines Committee for Bladder Cancer as well as the boards of the Bladder Cancer Advocacy Network and the Duke Global Health Institute. He is the Chair of the LUGPA Education Committee. Dr Shore is on the editorial boards of Reviews in Urology, Urology Times, Chemotherapy Advisor, OncLive, PLOS ONE, Urology Practice, World Journal of Urology, and also serves as Editor, Everyday Urology-Oncology. He is a Fellow of the American College of Surgeons.